Eu Mdr Submission Guide

# EU MDR 2017/745 Submission Guide ## MDR Classification and Conformity Assessment Routes ### Class I Devices - **Self-certification** under Annex II - **Technical documentation** requirements per Annex II - **Declaration of Conformity** mandatory - **UDI registration** required ### Class IIa Devices - **Notified Body involvement** for Annex III Module C2 + Annex V - **Quality management system** assessment - **Technical documentation** review - **Ongoing surveillance** requirements ### Class IIb Devices - **Notified Body certification** under Annex III Module B + C or D - **Type examination** or **Full quality assurance** route - **Design examination** requirements - **Production surveillance** obligations ### Class III Devices - **Comprehensive Notified Body assessment** - **Type examination** + production surveillance OR - **Full quality assurance** system approach - **Design dossier** requirements per Annex II ## Key MDR Submission Requirements ### 1. Technical Documentation (Annex II) - Device description and intended purpose - Risk management documentation (ISO 14971) - Clinical evidence per Annex XIV - Post-market surveillance plan - Performance evaluation reports ### 2. Quality Management System (Annex I, Chapter II) - ISO 13485 compliant QMS - Design controls implementation - Risk management integration - Clinical evaluation procedures - Post-market surveillance system ### 3. Clinical Evidence Requirements - **Clinical evaluation plan** per Annex XIV - **Literature review** and gap analysis - **Clinical investigation** if required - **Post-market clinical follow-up** plan - **Clinical evaluation report** updating ### 4. UDI System Implementation - **UDI-DI assignment** and registration - **UDI-PI requirements** for higher risk devices - **EUDAMED registration** obligations - **Labeling compliance** with UDI requirements ## Submission Timeline Framework ### Pre-Submission Phase (6-12 months) 1. **Gap analysis** against MDR requirements 2. **Classification confirmation** with regulatory experts 3. **Notified Body selection** and preliminary discussions 4. **Clinical evidence strategy** development 5. **UDI strategy** and EUDAMED preparation ### Submission Preparation (3-6 months) 1. **Technical documentation** compilation 2. **QMS documentation** review and update 3. **Clinical evaluation** completion 4. **Risk management** file finalization 5. **Notified Body application** submission ### Review and Certification (6-18 months) 1. **Initial assessment** by Notified Body 2. **Questions and clarifications** response 3. **Audit activities** coordination 4. **Certificate issuance** and market access 5. **Post-market obligations** activation ## Critical Success Factors - **Early engagement** with chosen Notified Body - **Robust clinical evidence** strategy and execution - **Comprehensive risk management** throughout lifecycle - **Proactive post-market surveillance** system - **Regular monitoring** of regulatory updates and guidance ## Common Pitfalls to Avoid - **Insufficient clinical evidence** planning - **Late Notified Body engagement** - **Inadequate post-market surveillance** systems - **Poor documentation quality** and traceability - **Underestimating timeline** and resource requirements